Vascular endothelial growth factor in heart failure

Z Taimeh, J Loughran, EJ Birks, R Bolli - Nature reviews cardiology, 2013 - nature.com
Heart failure is a devastating condition, the progression of which culminates in a mismatch of
oxygen supply and demand, with limited options for treatment. Heart failure has several …

Therapeutic angiogenesis for heart failure

JM Isner, DW Losordo - Nature medicine, 1999 - nature.com
Therapeutic angiogenesis for heart failure | Nature Medicine Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …

Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine

S Ylä-Herttuala, TT Rissanen, I Vajanto… - Journal of the american …, 2007 - jacc.org
Members of the vascular endothelial growth factor (VEGF) family are among the most
powerful modulators of vascular biology. They regulate vasculogenesis, angiogenesis, and …

[HTML][HTML] Vascular endothelial growth factor B and its signaling

N Lal, K Puri, B Rodrigues - Frontiers in cardiovascular medicine, 2018 - frontiersin.org
In diabetes, compromised glucose utilization leads the heart to use FA almost exclusively for
ATP generation. Chronically, this adaptation unfortunately leads to the conversion of FA to …

VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond

M Giacca, S Zacchigna - Gene therapy, 2012 - nature.com
Despite the enormous progress made in terms of prevention and early intervention, a
pressing need remains to develop innovative therapeutic strategies for ischemic …

Vascular endothelial growth factor biology for regenerative angiogenesis

A Uccelli, T Wolff, P Valente, N Di Maggio… - Swiss medical …, 2019 - smw.ch
Despite major advances in medical, catheter-based or surgical treatment, cardiovascular
diseases such as peripheral artery disease and coronary artery disease still cause …

Cardiomyocyte VEGFR‐1 activation by VEGF‐B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction

L Zentilin, U Puligadda, V Lionetti… - The FASEB …, 2010 - Wiley Online Library
Mounting evidence indicates that the function of members of the vascular endothelial growth
factor (VEGF) family extends beyond blood vessel formation. Here, we show that the …

Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor

I Zachary, A Mathur, S Yla-Herttuala… - … , and vascular biology, 2000 - Am Heart Assoc
There is widespread interest in the use of the angiogenic cytokine, vascular endothelial
growth factor (VEGF), for the treatment of cardiovascular disease. The main paradigm for …

Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy

F Woitek, L Zentilin, NE Hoffman, JC Powers… - Journal of the American …, 2015 - jacc.org
Background: Vascular endothelial growth factor (VEGF)-B activates cytoprotective/
antiapoptotic and minimally angiogenic mechanisms via VEGF receptors. Therefore, VEGF …

[HTML][HTML] The role of the VEGF family in coronary heart disease

Y Zhou, X Zhu, H Cui, J Shi, G Yuan, S Shi… - Frontiers in …, 2021 - frontiersin.org
The vascular endothelial growth factor (VEGF) family, the regulator of blood and lymphatic
vessels, is mostly investigated in the tumor and ophthalmic field. However, the functions it …